Related Experiment Video

Updated: Sep 27, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Multifactorial determination of hypertensive nephroangiosclerosis

Leszek Tylicki1, Boleslaw Rutkowski, Walter H Hörl

  • 1Department of Internal Medicine, Nephrology and Transplantology, Medical University, Gdansk, Poland.

Kidney & Blood Pressure Research
|February 19, 2003
PubMed

Insights

Essential hypertension can lead to kidney damage, known as hypertensive nephroangiosclerosis (HN). Understanding HN

Area of Science:

  • Nephrology
  • Cardiovascular Pathology

Background:

  • Essential hypertension is a primary cause of chronic kidney disease.
  • Hypertensive nephroangiosclerosis (HN) describes the renal pathology associated with hypertension.
  • The precise pathogenesis of hypertension-related renal scarring remains incompletely understood.

Purpose of the Study:

  • To review and discuss the current knowledge on the pathogenesis and risk factors of hypertensive nephroangiosclerosis.
  • To highlight factors beyond blood pressure that contribute to HN development and progression.
  • To emphasize the clinical importance of identifying all risk factors for patient management.

Main Methods:

  • Literature review and synthesis of existing research on hypertensive nephropathy.
  • Discussion of histological findings and etiological factors.
  • Analysis of contributing risk factors and genetic predispositions.

Main Results:

  • Histological lesions in HN are well-characterized.
  • Factors beyond elevated blood pressure, including aging, race, smoking, metabolic disturbances, substance abuse, environmental exposures, and diet, contribute to HN.
  • Renal susceptibility genes play a role in the severity of hypertension-induced renal damage.

Conclusions:

  • Hypertensive nephroangiosclerosis is a multifactorial condition.
  • Comprehensive assessment of all risk factors is crucial for identifying high-risk patients.
  • Tailored management strategies can be developed based on a thorough understanding of HN pathogenesis and risk factors.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...